Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands

Clinical Microbiology and Infection

Volumn 14, Issue 5, 2008, Pages 437-445

  van Duynhoven, Y T H P ^a   Friesema, I H M ^a   Schuurman, T ^b   Roovers, A ^c   van Zwet, A A ^d   Sabbe, L J M ^c   van der Zwaluw, W K ^a   Notermans, D W ^a   Mulder, B ^e   van Hannen, E J ^f   Heilmann, F G C ^g   Buiting, A ^h   Jansen, R ⁱ   Kooistra Smid, A M D ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Department of Research and Development ^*  (Netherlands)

^c Oosterschelde Hospital   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e Twente Achterhoek Laboratory for Microbiology   (Netherlands)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g GELRE HOSPITALS   (Netherlands)

^h CPRLab   (Netherlands)

ⁱ Laboratory of Public Health Haarlem   (Netherlands)

Author keywords

Diarrhoeagenic E. coli; E. coli 0157; Haemolytic uraemic syndrome; Shiga toxin; STEC; Surveillance

Indexed keywords

ANTIBIOTIC AGENT; SHIGA TOXIN;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOODY DIARRHEA; CONTROLLED STUDY; DIARRHEA; ENTEROBACTER INFECTION; EPIDEMIC; ESCHERICHIA COLI O157; FECES ANALYSIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 41949107648     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.01963.x     Document Type: Article

References (52)

1. Tarr PI, Gordon CA, Chandler WL. Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
2. Garg AX, Suri RS, Barrowman N et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome. JAMA 2003; 290: 1360-1370.
3. Suri RS, Clark WF, Barrowman N et al. Diabetes during diarrhea-associated hemolytic uremic syndrome. Diabetes Care 2005; 28: 2556-2562.
4. Havelaar AH, van Duynhoven YTHP, Nauta MJ et al. Disease burden in the Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiol Infect 2004; 132: 467-484.
5. de Wit MAS, Koopmans MPG, Kortbeek LM, van Leeuwen WJ, Bartelds AIM, van Duynhoven YTHP. Gastroenteritis in general practices in the Netherlands. Emerg Infect Dis 2001; 7: 82-91.
6. de Wit MAS, Koopmans MPG, Kortbeek LM et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: Incidence and aetiology. Am J Epidemiol 2001; 154: 666-674.
7. Hussein H-S. Prevalence and pathogenecity of Shiga toxin-producing Escherichia coli in beef cattle and their products. J Anim Sci 2007; 85 (suppl 13): E63-E72.
8. Hussein H-S, Sakuma T. Prevalence of Shiga toxin-producing Escherichia coli in dairy cattle and their products. J Anim Sci 2005; 88: 450-465.
9. Blanco JE, Blanco M, Alonso MP et al. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: Prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 2004; 42: 311-319.
10. Fruth A, Prager R, Friedrich A et al. Infektionen des menschen durch enterohämorrhagische Escherichia coli (EHEC) in der Bundesrepublik Deutschland von 1998 bis 2001. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2002; 45: 715-721.
11. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study. J Infect Dis 2002; 186: 493-500.
12. Scheutz F, Olsen KEP, Hoy Kock-Hansen G. Verocytotoxin-producing E. coli 2001-2002. Epi News 2003; 201: 1-2.
13. Tozzi AE, Caprioli A, Minelli F et al. Shiga toxin-producing E. coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003; 9: 106-108.
14. Brooks JT, Sowers EG, Wells JG et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 2005; 192: 1422-1429.
15. Lynn RM, O'Brien SJ, Taylor M et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005; 11: 590-596.
16. Manning SD, Madera RT, Schneider W et al. Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 2007; 13: 318-321.
17. Brooks JT, Bergmire-Sweat D, Kennedy M et al. Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clin Infect Dis 2004; 38: 190-198.
18. Allerberger F, Friedrich AW, Grif K et al. Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H- infection and consumption of unpasteurized cow's milk. Int J Infect Dis 2003; 7: 42-45.
19. Misselwitz J, Karch H, Bielazewska M et al. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr J Infect Dis 2003; 22: 349-354.
20. Scheutz F, Lassen J, Nygard K. VTEC O103 outbreak in Norway. EPI News 2006; 14: 1.
21. Werber D, Fruth A, Lieegang A et al. A multistate outbreak of Shiga toxin-producing Escherichia coli O26H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis 2002; 186: 419-422.
22. Espie E, Grimont F, Vaillant V et al. O148 Shiga toxin-producing Escherichia coli outbreak: Microbiological investigation as a useful complement to epidemiological investigation. Clin Microbiol Infect 2006; 12: 992-998.
23. McCarthy TA, Barrett NL, Hadler JL et al. Hemolytic-uremic syndrome and Escherichia coli O121 at a lake in Connecticut, 1999. Pediatrics 2001; 108: 59.
24. Van Duynhoven YTHP, de Jager CM, Heuvelink AE et al. Enhanced laboratory-based surveillance of Shiga toxin-producing Escherichia coli O157 in the Netherlands. Eur J Clin Microbiol Infect Dis 2002; 21: 513-522.
25. Heuvelink AE, van de Kar NCAJ, Meis JFGM, Monnens LAH, Melchers WJG. Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect 1995; 115: 1-14.
26. Te Loo DM, Heuvelink AE, De Boer E et al. Verocytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome. J Infect Dis 2001; 184: 446-450.
27. Ethelberg S, Olsen KEP, Scheutz F et al. Virulence factors for haemolytic uremic syndrome, Denmark. Emerg Infect Dis 2004; 10: 842-847.
28. Friedrich AW, Bielaszewska M, Zhang W-L et al. Escherichia coli harbouring Shiga toxin 2 gene variants: Frequency and association with clinical symptoms. J Infect Dis 2002; 185: 74-84.
29. Jenkins C, Willshaw GA, Evans J et al. Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J Med Microbiol 2003; 52: 941-947.
30. Schuurman T, Roovers A, van der Zwaluw WK et al. Evaluation of 5′-nuclease and hybridization probe assays for the detection of Shiga toxin-producing Escherichia coli in human stools. J Microbiol Methods 2007; 70: 406-415.
31. Blom M, Meyer A, Gerner-Smidt P, Gaarslev K, Espersen F. Evaluation of Statens Serum Institut Enteric Medium for detection of enteric pathogens. J Clin Microbiol 1999; 37: 2312-2316.
32. O157. J Clin Microbiol 1998; 36: 598-602.
33. Bennett-Wood VR, Russell J, Bordun A-M, Johnson PDR, Robins-Browne RM. Detection of enterohaemorrhagic Escherichia coli in patients attending hospital in Melbourne, Australia. Pathology 2004; 36: 345-351.
34. Welinder-Olsson C, Badenfors M, Cheasty T, Kjellin E, Kaijser B. Genetic profiling of enterohemorrhagic Escherichia coli strains in relation to clonality and clinical signs of infection. J Clin Microbiol 2002; 40: 959-964.
35. Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K. Characterization of shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 2004; 42: 1099-1108.
36. Eklund M, Scheutz F, Siitonen A. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: Serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J Clin Microbiol 2001; 39: 2829-2834.
37. Eklund M, Nuorti JP, Ruutu P, Siitonen A. Shigatoxigenic Escherichia coli (STEC) infections in Finland during 1998-2002: A population-based surveillance study. Epidemiol Infect 2001; 133: 845-852.
38. Elliott EJ, Robins-Browne RM, O'Loughlin EV et al. Nationwide study of haemolytic uraemic syndrome: Clinical, microbiological and epidemiological features. Arch Dis Childhood 2001; 85: 125-131.
39. Phan Q, Mshar P, Rabatsky-Her T et al. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli Connecticut, 2000-2005. MMWR 2007; 56: 29-31.
40. Anonymous. The Community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2005. EFSA J 2006; 94: 122-136.
41. Rivas M, Miliwebsky E, Chinen I et al. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Path Dis 2006; 3: 88-96.
42. Bielaszewska M, Prager R, Köck R et al. Shiga toxin gene loss and transfer in vivo and in vitro during enterohemorrhagic Escherichia coli O26 infections in human. Appl Environ Microbiol 2007; 73: 3144-3150.
43. Mellmann A, Bielaszewska M, Zimmerhackl LB et al. Enterohemorrhagic Escherichia coli in human infection: In vivo evolution of a bacterial pathogen. Clin Infect Dis 2005; 41: 785-792.
44. Karch H, Friedrich AW, Gerber A, Zimmerhackl LB, Schmidt A, Bielaszewska M. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin Thromb Hemost 2006; 32: 105-111.
45. Isobe J, Kimata K, Shimojima M, Hosorogi S, Tanaka D, Gyobu Y. Isolation of Escherichia coli O128:HNM harboring stx2f gene from diarrhea patients. Kansenshogaku Zasshi 2004; 78: 1000-1005 (in Japanese).
46. Ito K, Iida M, Yamazaki M et al. Intimin types determined by heteroduplex mobility assay of intimin gene (eae-) positive Escherichia coli strains. J Clin Microbiol 2007; 45: 1038-1041.
47. Morabito S, Dell'Omo G, Agrimi U et al. Detection and characterization of Shiga toxin-producing Escherichia coli in feral pigeons. Vet Microbiol 2001; 83: 275-283.
48. Caprioli A, Morabito S, Brugère H, Oswald E. Enterohaemorrhagic Escherichia coli: Emerging issues on virulence and modes of transmission. Vet Res 2005; 36: 289-311.
49. Beutin L, Zimmermann S, Gleier K. Evaluation of the VTEC-Screen 'Seiken' test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. Diagn Microbiol Infect Dis 2002; 42: 1-8.
50. Schmidt H, Scheef J, Morabito S, Caprioli A, Wieler LH, Karch H. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol 2000; 66: 1205-1208.
51. Beutin L, Steinrück H, Krause G et al. Comparative evaluation of the Ridascreen® verotoxin enzyme immunoassay for detection of Shiga toxin-producing strains of Escherichia coli (STEC) from food and other sources. J Appl Microbiol 2007; 102: 630-639.
52. Johnson KE, Thorpe CM, Sears CL. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 2006; 43: 1587-1595.